Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
British Journal of Cancer
|
November 13, 2021
CSNK2 in cancer: pathophysiology and translational applications
Scott W Strum, Laszlo Gyenis, David W Litchfield
Journal of Proteomics
|
September 29, 2012
Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2
Laszlo Gyenis, Agnieszka Kuś, Maria Bretner, et al.
Molecular and Cellular Biology
|
July 23, 2021
Correction for St-Denis et al., "Evidence for Regulation of Mitotic Progression through Temporal Phosphorylation and Dephosphorylation of CK2α"
Nicole A St-Denis, D Richard Derksen, David W Litchfield
Molecular and Cellular Biology
|
February 4, 2009
Evidence for regulation of mitotic progression through temporal phosphorylation and dephosphorylation of CK2alpha
Nicole A St-Denis, D Richard Derksen, David W Litchfield
Oncotarget
|
April 20, 2013
Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival
Jacob P Turowec, Greg Vilk, Michelle Gabriel, et al.
Molecular and Cellular Biochemistry
|
December 13, 2005
CK2 interacting proteins: emerging paradigms for CK2 regulation?
Mary Ellen K Olsten, Jane E Weber, David W Litchfield
Oncogene
|
May 29, 2002
Phosphorylation regulates the stability of the regulatory CK2beta subunit
Cunjie Zhang, Greg Vilk, David A Canton, et al.
Journal of Biomaterials Applications
|
February 10, 2017
Cellular interaction influenced by surface modification strategies of gelatin-based nanoparticles
Wai Hei Tse, Laszlo Gyenis, David W Litchfield, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 1, 2011
Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP
James S Duncan, Timothy A J Haystead, David W Litchfield
Biochimica Et Biophysica Acta. General Subjects
|
August 5, 2023
Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target
David W Litchfield, Laszlo Gyenis, Daniel Menyhart, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
British Journal of Cancer
|
November 13, 2021
CSNK2 in cancer: pathophysiology and translational applications
Scott W Strum, Laszlo Gyenis, David W Litchfield
Journal of Proteomics
|
September 29, 2012
Functional proteomics strategy for validation of protein kinase inhibitors reveals new targets for a TBB-derived inhibitor of protein kinase CK2
Laszlo Gyenis, Agnieszka Kuś, Maria Bretner, et al.
Molecular and Cellular Biology
|
July 23, 2021
Correction for St-Denis et al., "Evidence for Regulation of Mitotic Progression through Temporal Phosphorylation and Dephosphorylation of CK2α"
Nicole A St-Denis, D Richard Derksen, David W Litchfield
Molecular and Cellular Biology
|
February 4, 2009
Evidence for regulation of mitotic progression through temporal phosphorylation and dephosphorylation of CK2alpha
Nicole A St-Denis, D Richard Derksen, David W Litchfield
Oncotarget
|
April 20, 2013
Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival
Jacob P Turowec, Greg Vilk, Michelle Gabriel, et al.
Molecular and Cellular Biochemistry
|
December 13, 2005
CK2 interacting proteins: emerging paradigms for CK2 regulation?
Mary Ellen K Olsten, Jane E Weber, David W Litchfield
Oncogene
|
May 29, 2002
Phosphorylation regulates the stability of the regulatory CK2beta subunit
Cunjie Zhang, Greg Vilk, David A Canton, et al.
Journal of Biomaterials Applications
|
February 10, 2017
Cellular interaction influenced by surface modification strategies of gelatin-based nanoparticles
Wai Hei Tse, Laszlo Gyenis, David W Litchfield, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 1, 2011
Chemoproteomic characterization of protein kinase inhibitors using immobilized ATP
James S Duncan, Timothy A J Haystead, David W Litchfield
Biochimica Et Biophysica Acta. General Subjects
|
August 5, 2023
Towards the CSNK2 phosphoproteome - With lessons from the COVID-19 pandemic to revealing the secrets of CSNK2 and its promise as a therapeutic target
David W Litchfield, Laszlo Gyenis, Daniel Menyhart, et al.
Page
of 9